The programme spans multiple trials targeting distinct endpoints: On 21 May 2026 Eli Lilly reported topline results from TRIUMPH-1, the pivotal Phase 3 obesity trial and the programme's first Phase 3 efficacy readout: in 2,339 adults, mean weight loss at the 80-week primary endpoint reached 19.0% (4mg), 25.9% (9mg), and 28.3% (12mg) versus 2.2% for placebo (Eli Lilly investor release
And, uh and I would also I would also try to tr I also would try to convince my family and friends, uh, why they should be healthier and, particularly people that were not healthy
Strategies like eating adequate protein, getting enough fiber, and staying well hydrated can help support appetite control and satiety
prostaglandins: a group of lipid compounds derived from fatty acids (like arachidonic acid) that have diverse hormone-like effects in the body, including significant roles in inflammation, pain, fever, blood clotting, and protection of the gastric lining
They are patent-protected branded medications, and manufacturers set list price around research-cost recovery, market positioning, and expected payer mix